Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
abandoned, acetate, adult, advantage, advertising, aggregate, bank, biopharmaceutical, burden, Canadian, circumvented, composed, Consumer, costly, coverage, curtailment, desired, desmopressin, devote, difficult, disrupt, diverting, edit, ELAA, enact, enacted, encounter, enforce, etiology, exploit, factual, fail, failure, field, foregoing, governmental, guaranty, harm, highly, incorrect, indemnity, infringed, ingredient, integration, interaction, interrupted, intranasal, Lakewood, legislative, mandatory, manner, manufacture, manufacturer, manufacturing, match, Medicare, medicine, Noctiva, nocturia, nocturnal, opportunity, overestimated, past, payor, polyuria, profile, promoting, promotion, Renaissance, resistance, retirement, saving, scientific, Serenity, slighly, smaller, stricter, substitute, supplier, supply, therapy, tolerability, twelve, unable, unavailable, underestimate, upfront, upheld, urination, waived
Removed:
approximating, dedicated, implemented, medical, operate, UMD, unmet
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8A
- 10.8 Exhibit 10.8B
- 10.9 Exhibit 10.9
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- 32.2 Exhibit 32.2
- Download Excel data file
- View Excel data file
Related press release
Associated AVDL transcripts
AVDL similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc (the “Company”) for the period ended September 30, 2017 (the “Report”), the undersigned hereby certifies in his capacity as Chief Financial Officer of the Company pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 9, 2017 | /s/ Michael F. Kanan |
| Michael F. Kanan | |
Senior Vice President and Chief Financial Officer (Principal Financial Officer) | |